The carbohydrate-linked phosphorylcholine of the parasitic nematode product ES-62 modulates complement activation

Ahmed, Umul Kulthum and Maller, N. Claire and Iqbal, Asif J. and Al-Riyami, Lamyaa and Harnett, William and Raynes, John G. (2016) The carbohydrate-linked phosphorylcholine of the parasitic nematode product ES-62 modulates complement activation. Journal of Biological Chemistry, 291 (22). pp. 11939-11953. ISSN 1083-351X

[img]
Preview
Text (Ahmed-etal-JBC-2016-The-carbohydrate-linked-phosphorylcholine-of-the-parasitic-nematode-product)
Ahmed_etal_JBC_2016_The_carbohydrate_linked_phosphorylcholine_of_the_parasitic_nematode_product.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (2MB)| Preview

    Abstract

    Parasitic nematodes manufacture various carbohydratelinked phosphorylcholine (PCh)-containing molecules, including ES-62, a protein with an N-linked glycan terminally substituted with PCh. The PCh component is biologically important because it is required for immunomodulatory effects. We showed that most ES-62 was bound to a single protein, C-reactive protein (CRP), in normal human serum, displaying a calcium-dependent, high-avidity interaction and ability to form large complexes. Unexpectedly, CRP binding to ES-62 failed to efficiently activate complement as far as the C3 convertase stage in comparison with PCh-BSA and PCh-containing Streptococcus pneumoniae cell wall polysaccharide. C1q capture assays demonstrated an ES-62-CRP-C1q interaction in serum. The three ligands all activated C1 and generated C4b to similar extents. However, a C2a active site was not generated following ES-62 binding to CRP, demonstrating that C2 cleavage was far less efficient for ES-62-containing complexes. We proposed that failure of C2 cleavage was due to the flexible nature of carbohydrate-bound PCh and that reduced proximity of the C1 complex was the reason that C2 was poorly cleaved. This was confirmed using synthetic analogues that were similar to ES-62 only in respect of having a flexible PCh. Furthermore, ES-62 was shown to deplete early complement components, such as the rate-limiting C4, following CRP interaction and thereby inhibit classical pathway activation. Thus, flexible PCh-glycan represents a novel mechanism for subversion of complement activation. These data illustrate the importance of the rate-limiting C4/C2 stage of complement activation and reveal a new addition to the repertoire of ES-62 immunomodulatory mechanisms with possible therapeutic applications.